Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway

Arthritis and Rheumatism

Volumn 58, Issue 1, 2008, Pages 209-220

  Gilbert, S J ^a,b   Blain, E J ^a   Duance, V C ^a   Mason, D J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CERAMIDE; COLLAGEN TYPE 2; CYTOKINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C FOS; RAF PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; COW; ENZYME PHOSPHORYLATION; FARBER DISEASE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; CULTURE MEDIA; DOWN-REGULATION; GENES, IMMEDIATE-EARLY; HIGH MOBILITY GROUP PROTEINS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-RAF; RNA, MESSENGER; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTORS;

EID: 38149114635     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23172     Document Type: Article

References (50)

1. Goldring MB. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models [review]. Connect Tissue Res 1999;40:1-11.
2. Ruvolo PP. Ceramide regulates cellular homeostasis via diverse stress signaling pathways [review]. Leukemia 2001;15:1153-60.
3. Gilbert SJ, Duance VC, Mason DJ. Does protein kinase R mediate TNF-α- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism? Arthritis Res Ther 2004;6:R46-55.
4. Sabatini M, Rolland G, Leonce S, Thomas M, Lesur C, Perez V, et al. Effects of ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage. Biochem Biophys Res Commun 2000;267:438-44.
5. Sabatini M, Thomas M, Deschamps C, Lesur C, Rolland G, de Nanteuil G, et al. Effects of ceramide on aggrecanase activity in rabbit articular cartilage. Biochem Biophys Res Commun 2001; 283:1105-10.
6. Gilbert SJ, Blain EJ, Jones P, Duance VC, Mason D. Exogenous sphingomyelinase increases collagen and sulphated glycosaminoglycan production by primary articular chondrocytes: an in vitro study. Arthritis Res Ther 2006;8:R89-100.
7. 2 from human articular chondrocytes. BMC Musculoskelet Disord 2007;8:29.
8. Kitano M, Hla T, Sekiguchi M, Kawahito Y, Yoshimura R, Miyazawa K, et al. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum 2006;54:742-53.
9. Ehlert K, Frosch M, Fehse N, Zander A, Roth J, Vormoor J. Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr Rheumatol Online J 2007;5:15.
10. Farina F, Cappello F, Todaro M, Bucchieri F, Peri G, Zummo G, et al. Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease. J Histochem Cytochem 2000;48:57-62.
11. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 1994;78:1005-15.
12. Mathias S, Kolesnick R. Ceramide: a novel second messenger. Adv Lipid Res 1993;25:65-90.
13. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 1996;86:937-47.
14. Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LM, et al. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-α/cycloheximide- induced cerebral endothelial cell death. J Biol Chem 1998;273:16521-6.
15. Hannun YA, Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol 2000;10:73-80.
16. Colell A, Coll O, Mari M, Fernandez-Checa JC, Garcia-Ruiz C. Divergent role of ceramide generated by exogenous sphingomy-elinases on NF-κB activation and apoptosis in human colon HT-29 cells. FEBS Lett 2002;526:15-20.
17. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992;71:765-76.
18. Muller G, Storz P, Bourteele S, Doppler H, Pfizenmaier K, Mischak H, et al. Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J 1998;17:732-42.
19. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick R. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 1995;378:307-10.
20. Huwiler A, Xin C, Brust AK, Briner VA, Pfeilschifter J. Differential binding of ceramide to MEKK1 in glomerular endothelial and mesangial cells. Biochim Biophys Acta 2004;1636:159-68.
21. Willaime S, Vanhoutte P, Caboche J, Lemaigre-Dubreuil Y, Mariani J, Brugg B. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci 2001;13: 2037-46.
22. MacRae VE, Burdon T, Ahmed SF, Farquharson C. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent. J Endocrinol 2006;191:369-77.
23. Huwiler A, Brunner J, Hummel R, Vervoordeldonk M, Stabel S, van den Bosch H, et al. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A 1996;93:6959-63.
24. Giltiay NV, Karakashian AA, Alimov AP, Ligthlc S, Nikolova-Karakashian MN. Ceramide- and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1β in hepatocytes. J Lipid Res 2005;46:2497-505.
25. Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, et al. Tumor necrosis factor-α supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 2001;276: 49343-9.
26. Pru JK, Lynch MP, Davis JS, Rueda BR. Signaling mechanisms in tumor necrosis factor α-induced death of microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 2003;1:17.
27. Fan Z, Yang H, Bau B, Soder S, Aigner T. Role of mitogen-activated protein kinases and NFκB on IL-1β-induced effects on collagen type II, MMP-1 and 13 mRNA expression in normal articular human chondrocytes. Rheumatol Int 2006;26:900-3.
28. Hung CT, Henshaw DR, Wang CC, Mauck RL, Raia F, Palmer G, et al. Mitogen-activated protein kinase signaling in bovine articular chondrocytes in response to fluid flow does not require calcium mobilization. J Biomech 2000;33:73-80.
29. Fusello AM, Mandik-Nayak L, Shih F, Lewis RE, Allen PM, Shaw AS. The MAPK scaffold kinase suppressor of Ras is involved in ERK activation by stress and proinflammatory cytokines and induction of arthritis. J Immunol 2006;177:6152-8.
30. Gortz B, Hayer S, Tuerck B, Zwerina J, Smolen JS, Schett G. Tumour necrosis factor activates the mitogen-activated protein kinases p38a and ERK in the synovial membrane in vivo. Arthritis Res Ther 2005;7:R1140-7.
31. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 2002;4:556-64.
32. Tsuji M, Funahashi S, Takigawa M, Seiki M, Fujii K, Yoshida T. Expression of c-fos gene inhibits proteoglycan synthesis in transfected chondrocyte. FEBS Lett 1996;381:222-6.
33. Tsuji M, Hirakawa K, Kato A, Fujii K. The possible role of c-fos expression in rheumatoid cartilage destruction. J Rheumatol 2000; 27:1606-21.
34. Jacques C, Recklies AD, Levy A, Berenbaum F. HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions. Osteoarthritis Cartilage 2007;15:138-46.
35. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro α1(II) collagen gene. Mol Cell Biol 1997;17: 2336-46.
36. Shakibaei M, Seifarth C, John T, Rahmanzadeh M, Mobasheri A. Igf-I extends the chondrogenic potential of human articular chondrocytes in vitro: molecular association between Sox9 and Erk1/2. Biochem Pharmacol 2006;72:1382-95.
37. Blain EJ, Gilbert SJ, Duance VC. Disassembly of the vimentin cytoskeleton disrupts articular cartilage chondrocyte homeostasis. Matrix Biology 2006;25:398-408.
38. Patel CV, Handy I, Goldsmith T, Patel RC. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem 2000; 275:37993-8.
39. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270: 27489-94.
40. Lackey K, Cory M, Davis R, Frye SV, Harris PA, Hunter RN, et al. The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett 2000;10:223-6.
41. Vaughan-Thomas A, Gilbert SJ, Duance VC. Elevated levels of proteolytic enzymes in the aging human vitreous. Invest Ophthalmol Vis Sci 2000;41:3299-304.
42. Li KW, Wang AS, Sah RL. Microenvironment regulation of extracellular signal-regulated kinase activity in chondrocytes: effects of culture configuration, interleukin-1, and compressive stress. Arthritis Rheum 2003;48:689-99.
43. Kim MY, Linardic C, Obeid L, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-interferon: specific role in cell differentiation. J Biol Chem 1991;266:484-9.
44. Dbaibo GS, Obeid LM, Hannun YA. Tumor necrosis factor-α (TNF-α) signal transduction through ceramide: dissociation of growth inhibitory effects of TNF-α from activation of nuclear factor-κB. J Biol Chem 1993;268:17762-6.
45. Costa M, Marchi M, Cardarelli F, Roy A, Beltram F, Maffei L, et al. Dynamic regulation of ERK2 nuclear translocation and mobility in living cells. J Cell Sci 2006;119:4952-63.
46. Caunt CJ, Finch AR, Sedgley KR, McArdle CA. Seven-transmembrane receptor signalling and ERK compartmentalization. Trends Endocrinol Metab 2006;17:276-83.
47. Okazaki K, Sagata N. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J 1995;14:5048-59.
48. Murakami S, Lefebvre V, de Crombrugghe B. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-α. J Biol Chem 2000;275:3687-92.
49. Kypriotou M, Fossard-Demoor M, Chadjichristos C, Ghayor C, de Crombrugghe B, Pujol JP, et al. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state. DNA Cell Biol 2003;22: 119-29.
50. Gasca S, Canizares J, De Santa Barbara P, Mejean C, Poulat F, Berta P, et al. A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination. Proc Natl Acad Sci U S A 2002;99:11199-204.